Skip to main content
BEOVU 6 mg/.05mL injection, solution by Novartis Pharmaceuticals Corporation
BEOVU, 6 mg/.05mL, injection, solution Available on prescription only. Listed by Novartis Pharmaceuticals Corporation.
Prescription only

BEOVU

brolucizumab

Listed by Novartis Pharmaceuticals Corporation

Strength
6 mg/.05mL
Form
Injection, Solution
Route
Intravitreal

What it contains

  • Brolucizumab 6 mg/.05mL

FDA record

Dosage form Injection, Solution
Route Intravitreal
Approval route BLA — biologic licence
NDC code 0078-0827
FDA application BLA761125
RxNorm concept 2204920
Package sizes listed 2
Marketed since October 2019

Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.